AI Terminal
Novonesis AS
Transaction in Own Shares • Feb 21, 2022
3377_dirs_2022-02-21_23b58472-0dcd-49ab-9f7b-6cef34777cfd.pdf
Transaction in Own Shares
Open in ViewerOpens in native device viewer
Initiation of stock buyback program
On February 21, 2022, Novozymes will initiate a stock buyback program as announced in Company Announcement No. 1, of February 1, 2022. Under the program Novozymes will buy back B shares worth up to DKK 500 million in total during the remainder of 2022, corresponding to around 1.3 million B shares at the current share price. The program is contingent upon no major strategic initiatives being decided upon that will require a significant amount of capital.
The shares acquired in the program will be used to meet obligations arising from employee stockbased incentive programs and/or to reduce the common stock. The cancelation of stock will take place after the program is finished and will be subject to approval at the Annual Shareholders' Meeting.
The maximum number of shares to be purchased by the company per daily market session will be equivalent to no more than 25% of the average volume of shares in the company traded on NASDAQ OMX Copenhagen during the preceding 20 business days. The program will run in accordance with the commission regulation (EU) 596/2014 of 16 April 2014, also known as the "Market Abuse Regulation", and commission regulation (EU) 1052/2016 of 8 March 2016.
February 21, 2022 Company announcement No. 2
Contact information [email protected]
Tobias Cornelius Björklund +45 3077 8682 [email protected]
Carl Ahlgren +1 919 702 6144 [email protected]
Ulrik Wu Svare +45 3077 3187 [email protected]
About Novozymes
Novozymes is the world leader in biological solutions. Together with customers, partners and the global community, we improve industrial performance while preserving the planet's resources and helping build better lives. As the world's largest provider of enzyme and microbial technologies, our bioinnovation enables higher agricultural yields, low-temperature washing, energyefficient production, renewable fuel and many other benefits that we rely on today and in the future. We call it Rethink Tomorrow. www.novozymes.com
Novozymes A/S CVR number: 10 00 71 27 LEI: 529900T6WNZXD2R3JW38
Novozymes A/S Krogshoejvej 36 2880 Bagsvaerd Denmark
Phone: +45 4446 0000
